News Archive

Berenberg names Admiral among top picks in European insurance

22nd Apr 2025 11:10

(Sharecast News) - Berenberg analysts have named UK-listed motor insurer Admiral among their top picks in the European insurance sector.

Read more

Europe midday: Stoxx extends losses as Trump/Powell spat spooks investors

22nd Apr 2025 11:01

(Sharecast News) - European shares extended losses on Tuesday and gold hit $3,500 for the first time amid concerns over the US Federal Reserve's independence after attacks on its boss Jerome Powell by President Donald Trump and the lack of progress on tariff negotiations by Washington.

Read more

AOTI gets TWO2 included on NHS Supply Chain framework

22nd Apr 2025 10:09

(Sharecast News) - AOTI announced on Tuesday that it has secured inclusion of its Topical Wound Oxygen (TWO2) therapy in the NHS Supply Chain framework agreement for advanced wound care, effective from 1 September.

Read more

US pre-open: Futures higher following Monday's sell-off

22nd Apr 2025 10:06

(Sharecast News) - Wall Street futures had major indices reclaiming some of yesterday's losses as markets remain volatile following the announcement of Donald Trump's "reciprocal" tariffs earlier this month.

Read more

Orosur Mining consultant exercises stock options

22nd Apr 2025 10:04

(Sharecast News) - Orosur Mining announced the issue of 83,333 new shares on Tuesday, following the exercise of stock options by a company consultant at an exercise price of six Canadian cents per share.

Read more

Helium One reports encouraging flow testing at Jackson-29

22nd Apr 2025 10:01

(Sharecast News) - Helium One Global reported encouraging flow test results from the Jackson-29 well at the Galactica Project in Colorado on Tuesday, where it holds a 50% working interest in a joint venture with Blue Star Helium.

Read more

Roche to spend $50bn on US manufacturing, R&D sites

22nd Apr 2025 10:00

(Sharecast News) - Swiss healthcare giant Roche announced on Tuesday that it is planning to spend $50bn in pharmaceuticals and diagnostics in the US over the next five years.

Read more

Ebiquity confident after second-half turnaround

22nd Apr 2025 09:57

(Sharecast News) - Ebiquity reported a 4.3% decline in revenue to £76.8m for the year ended 31 December on Tuesday, with adjusted operating profit falling 34.3% to £7.9m.

Read more

Clean Power Hydrogen appoints chief commercial officer

22nd Apr 2025 09:52

(Sharecast News) - Clean Power Hydrogen announced the appointment of Richard Scott as its chief commercial officer on Tuesday, effective 1 July, as it moved into the next phase of its commercial strategy.

Read more

Berenberg upgrades Energean to 'buy'

22nd Apr 2025 09:36

(Sharecast News) - Analysts at Berenberg upgraded exploration and production outfit Energean from 'hold' to 'buy' on Tuesday, stating the group appeared to be "resilient" to current market volatility.

Read more

Mkango and CoTec appoint lead engineers for DFW hub project

22nd Apr 2025 09:35

(Sharecast News) - Mkango Resources, alongside its partner CoTec Holdings, announced the appointment of PegasusTSI and BBA USA on Tuesday, to provide engineering, procurement and construction management (EPCM) services for the HyProMag USA rare earth magnet recycling and manufacturing project in the Dallas-Fort Worth area.

Read more

Celebrus Technologies FY25 revenues seen falling short of expectations

22nd Apr 2025 09:29

(Sharecast News) - Data solutions provider Celebrus Technologies warned on Tuesday that FY25 revenues were expected to fall short of expectations amid a slow down in customer decision making due to the "increasingly uncertain" global geopolitical situation.

Read more

ITM Power raises full-year revenue guidance

22nd Apr 2025 09:08

(Sharecast News) - ITM Power raised its full-year revenue guidance for 2025 on Tuesday, to between £25.5m and £26.5m, reflecting a 30% increase on the midpoint of its previous range of £18m to £22m.

Read more

Shield Therapeutics inks exclusive licence agreement in Japan

22nd Apr 2025 09:03

(Sharecast News) - Pharmacitucal firm Shield Therapeutics said on Tuesday that it had inked an exclusive licence agreement for its ACCRUFeR iron deficiency asset in Japan with VITAL-NET.

Read more

Hutchmed enrols patients for phase two savolitinib trial

22nd Apr 2025 08:46

(Sharecast News) - Hutchmed China announced on Tuesday that it has completed patient enrollment for the registration phase of its phase two clinical trial, evaluating savolitinib in Chinese patients with MET-amplified gastric cancer or gastroesophageal junction adenocarcinoma.

Read more